Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF OCTOBER 03, 2002 FBO #0305
MODIFICATION

A -- A-Innovative Therapies for Rheumatic and Skin Diseases

Notice Date
7/6/2001
 
Notice Type
Modification
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 45 Center Drive, Room 5AS13A, MSC 6500, Bethesda, MD, 20892-6500
 
ZIP Code
20892-4872
 
Solicitation Number
NIH-NIAMS-BAA-02-01
 
Response Due
11/15/2001
 
Point of Contact
Eileen Webster-Cissel, Chief Contracting Officer, Phone 301-594-2543, Fax 301-480-5996,
 
E-Mail Address
ew52c@nih.gov
 
Small Business Set-Aside
N/A
 
Description
This announces the availability of a Broad Agency Announcement (BAA) which describes in general terms a research topic and outlines proposal preparation requirements. The purpose of this BAA is to solicit proposals to carry out pilot/feasibility (open label, phase I/II) clinical studies to establish the safety and gather enough preliminary evidence of efficacy of new and innovative therapeutic approaches to rheumatic and skin diseases of children and/or adults, and to design and implement basic or clinical research ancillary projects linked to the clinical trial protocol. The goal of this initiative is to accelerate the application of new drugs, biologicals and other non-behavioral interventions for the short and long term management of symptoms, signs, systemic and structural changes in patients with established rheumatic and skin diseases and for the development of strategies for prevention of disease onset, progression or structural damage to target organs in patients at high risk. New and emerging agents and approaches for the treatment of lupus, rheumatoid arthritis, scleroderma, myositis, Sjogren's and other rheumatic diseases are included. In the skin diseases area, inflammatory, autoimmune, and genetic skin diseases are included as are small trials for innovative therapies on wound healing. It is anticipated that three to five cost reimbursement contract awards will be made for a maximum period of five years beginning on or about May 30, 2002. The solicitation NIH-NIAMS-BAA-02-01 will be available electronically on or about July 23, 2001 and may be accessed through the Internet at the following address: http://www.nih.gov/niams/grants/rfp/rfplist.htm. Proposals will be due on or about November 15, 2001. Offerors are responsible for downloading their own copy of the solicitation and amendments and for routinely checking the Internet site for any possible solicitation amendments that may be issued by the Government. All responsible sources may submit proposals which will be considered by the Government. The North American Industrial Classification System (NAICS) code for this acquisition is 541710. This advertisement does not commit the Government to award a contract.***** NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS.GOV ON THE DATE INDICATED IN THE NOTICE ITSELF (06-JUL-2001). IT ACTUALLY FIRST APPEARED ON THE FEDBIZOPPS SYSTEM ON 01-OCT-2002. PLEASE CONTACT fbo.support@gsa.gov REGARDING THIS ISSUE.
 
Web Link
Link to FedBizOpps document.
(http://www.eps.gov/spg/HHS/NIH/NIAMSD/NIH-NIAMS-BAA-02-01/listing.html)
 
Place of Performance
Address: N/A
 
Record
SN00180305-F 20021003/021001220319 (fbodaily.com)
 
Source
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.